Members of the wealthy Sackler family, owners of OxyContin maker Purdue Pharma LP, have long denied that the $10 billion they transferred from their company over the course of a decade was an unlawful attempt to shield assets in anticipation of litigation over their role in the opioid crisis. But a review of emails, memos,… Continue reading Documents Show Sacklers Cited Fear of OxyContin Lawsuits before Transferring $10B from Company
Looking For Market Distribution? Download the Media Kit
